Trending archive

Every article that has appeared in Trending stays here. Search by title, journal, author or PMID, and narrow by date.

AllClinical ResearchCase Reports
Last 30 daysLast 3 monthsThis year

557 articles

October 20251

Case ReportHematology

Innovative sequential therapy in a rare case of refractory Erdheim-Chester disease with bilateral pulmonary involvement.

A 44-year-old man with Erdheim-Chester disease confirmed by lung biopsy presented with persistent fatigue, intermittent low-grade fever, and bilateral interstitial lung disease.

J ChemotherOct 6, 2025Read case

August 20252

Case ReportHematologyOpen access

Genetic background of Richter transformation of atypical chronic lymphocytic leukemia to diffuse large B-cell lymphoma - a case study.

A 29-year-old woman with atypical chronic lymphocytic leukemia (aCLL) was initially treated with fludarabine, cyclophosphamide, and rituximab.

J Appl GenetAug 9, 2025Read case
Case ReportHematology

Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease.

A 38-year-old man presented with persistent dry cough, generalized lymphadenopathy, and fatigue, with elevated serum IgG4. Inguinal lymph node biopsy showed plasma cell-type multicentric Castleman disease, including…

J ChemotherAug 5, 2025Read case

June 20251

Clinical ResearchHematology

Risk of musculoskeletal disorders associated with Bruton's tyrosine kinase inhibitors: a disproportionality analysis of FAERS database and meta-analysis.

This study examined musculoskeletal adverse events associated with Bruton's tyrosine kinase inhibitors (BTKis) using a retrospective case/non-case disproportionality analysis of FAERS reports through Q2 2024 and a…

Expert Opin Drug SafJun 18, 2025Read summary

April 20251

Clinical ResearchHematology

Safety, effectiveness and pharmacokinetics of high-dose propylene glycol-free melphalan (EVOMELA) with a prolonged infusion as myeloablative conditioning in Chinese multiple myeloma patients undergoing autologous stem cell transplantation: A prospective phase iv study.

This prospective, open-label, non-randomized phase IV study evaluated prolonged-infusion, high-dose BSES-melphalan conditioning in 67 Chinese patients with multiple myeloma undergoing autologous stem cell…

J Oncol Pharm PractApr 29, 2025Read summary

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.